Searchable abstracts of presentations at key conferences in endocrinology

ea0059mte2 | GC metabolic health | SFEBES2018

Glucocorticoids in metabolic health: Effects of selective GR modulators

Meijer Onno

Endogenous glucocorticoids help to mobilize energy to prepare for daily activity and to deal with stressors, e.g. by catabolic effects on muscle and stimulation of the release of glucose and fat from the liver. Chronic overexposure to glucocorticoids has strong deleterious effects, in medical glucocorticoid and in Cushing’s disease. It is less clear to what extent glucocorticoid signalling may be used as a therapeutic target in the much more frequent consequences of the m...

ea0056p611 | Steroid metabolism + action | ECE2018

Sex differences in glucocorticoid-induced metabolic disturbances in mice

Kaikaew Kasiphak , Steenbergen Jacobie , Kroon Jan , Meijer Onno C , Grefhorst Aldo , Visser Jenny A

Introduction: Glucocorticoids (GCs) are widely used anti-inflammatory medications that cause many metabolic side effects. Long-term treatment with GCs causes obesity and induces insulin resistance in many metabolic tissues, including adipose tissue and muscle. Factors secreted by adipose tissue, so-called adipokines, including leptin and adiponectin, also regulate the glucose-insulin axis. Obesity increases circulating leptin but decreases adiponectin levels. Despite several s...

ea0050p005 | Adrenal and Steroids | SFEBES2017

20β-Dihydrocortisol; a weak endogenous agonist of the glucocorticoid receptor but a potent agonist of the mineralocorticoid receptor

Morgan Ruth , Beck Katharina , Nixon Mark , Homer Natalie , Melchers Diana , Houtman Rene , Meijer Onno , Hadoke Patrick , Odermatt Alex , Keen John , Walker Brian

Cortisol conversion to 20β-dihydrocortisol (20β-DHF) has been reported in many tissues and cells, including skin, muscle, thrombocytes and fibroblasts, although the enzyme responsible is poorly characterised. We have attributed 20β-DHF generation to carbonyl reductase 1 and shown increased activity of this pathway in adipose tissue in obesity in humans, horses and mice. This study addressed the hypothesis that 20β-DHF activates gl...

ea0050p005 | Adrenal and Steroids | SFEBES2017

20β-Dihydrocortisol; a weak endogenous agonist of the glucocorticoid receptor but a potent agonist of the mineralocorticoid receptor

Morgan Ruth , Beck Katharina , Nixon Mark , Homer Natalie , Melchers Diana , Houtman Rene , Meijer Onno , Hadoke Patrick , Odermatt Alex , Keen John , Walker Brian

Cortisol conversion to 20β-dihydrocortisol (20β-DHF) has been reported in many tissues and cells, including skin, muscle, thrombocytes and fibroblasts, although the enzyme responsible is poorly characterised. We have attributed 20β-DHF generation to carbonyl reductase 1 and shown increased activity of this pathway in adipose tissue in obesity in humans, horses and mice. This study addressed the hypothesis that 20β-DHF activates gl...

ea0037gp.21.03 | Pituitary – Diagnosis of Cushing's disease | ECE2015

Altered neural processing during emotional faces in remitted Cushing's disease

Andela Cornelie , Hoogendam Janna Marie , Van der Werff Steven , Pannekoek Nienke , Van Steenbergen Henk , Meijer Onno , Van Buchem Mark , Rombouts Serge , Van der Mast Roos , Biermasz Nienke , Van der Wee Nic , Pereira Alberto

Background: Patients with long-term remission of Cushing’s disease (CD) demonstrate residual psychological complaints. At present, it is not known how previous exposure to hypercortisolism affects psychological functioning in the long-term. In foregoing Magnetic Resonance Imaging (MRI) studies, abnormalities of brain structure and resting-state connectivity were demonstrated in patients with long-term remission of CD. However, no data are available on functional alteratio...